sep
27
2017
CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA
sep
15
2017
Bien vivre avec la LLC à Montréal
juin
05
2017
If you have or had Hodgkin lymphoma or you are or were a caregiver of a patient with Hodgkin lymphoma, you can help by completing our surveys.
fév
13
2017
New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's lymphoma
Jan
05
2017
Promising results [10.1016/j.ymthe.2016.10.020] from the phase 1 portion of a multi-center phase
nov
18
2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for ibrutinib (Imbruvica) for first-line treatment of chronic lymphocytic leukemia (CLL).
nov
18
2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for ibrutinib (Imbruvica) for Waldenstrom's Macroglobulinemia (WM).
oct
17
2016
On September 29, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for idelalisib (Zydelig) for follicular lymphoma.
